| Code | Description | Claims | Beneficiaries | Total Paid |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
30,445 |
29,437 |
$21.64M |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
165,319 |
162,146 |
$8.57M |
| G0378 |
Hospital observation service, per hour |
2,598 |
2,490 |
$8.13M |
| 87633 |
Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets |
4,375 |
4,307 |
$3.23M |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
102,964 |
95,415 |
$2.70M |
| 76816 |
Ultrasound, pregnant uterus, real time with image documentation, follow-up |
12,552 |
11,359 |
$2.46M |
| 42820 |
Tonsillectomy and adenoidectomy; younger than age 12 |
664 |
639 |
$2.17M |
| 93303 |
Transthoracic echocardiography for congenital cardiac anomalies, follow-up or limited study |
5,314 |
5,170 |
$1.95M |
| 76819 |
Fetal biophysical profile; without non-stress testing |
11,900 |
8,410 |
$1.73M |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
31,058 |
28,758 |
$1.36M |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
23,830 |
23,415 |
$1.24M |
| 76811 |
Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, detailed |
5,354 |
4,992 |
$1.06M |
| 92587 |
|
4,749 |
4,593 |
$1.06M |
| C9803 |
Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
33,062 |
32,175 |
$888K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
11,561 |
11,417 |
$727K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
6,217 |
6,088 |
$541K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
17,541 |
8,870 |
$522K |
| 92579 |
|
3,603 |
3,505 |
$499K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
6,347 |
6,097 |
$496K |
| 92567 |
|
7,950 |
7,684 |
$440K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
7,306 |
7,190 |
$398K |
| 71046 |
Radiologic examination, chest; 2 views |
5,956 |
5,736 |
$393K |
| 69436 |
Tympanostomy (requiring insertion of ventilating tube), general anesthesia |
562 |
487 |
$375K |
| 95813 |
|
495 |
483 |
$339K |
| 70551 |
Magnetic resonance imaging, brain; without contrast material |
942 |
867 |
$319K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
5,307 |
5,214 |
$314K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
4,193 |
4,074 |
$261K |
| 94010 |
|
1,525 |
1,425 |
$260K |
| 87428 |
|
4,233 |
4,185 |
$246K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
8,850 |
8,643 |
$241K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
1,926 |
1,900 |
$175K |
| 72082 |
|
1,740 |
1,619 |
$171K |
| 76818 |
|
795 |
487 |
$171K |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
5,861 |
5,741 |
$167K |
| 80053 |
Comprehensive metabolic panel |
11,239 |
10,045 |
$164K |
| 95810 |
Polysomnography; sleep staging with 4 or more additional parameters |
66 |
65 |
$141K |
| D0120 |
Periodic oral evaluation - established patient |
4,943 |
4,743 |
$129K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
2,577 |
2,507 |
$126K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
2,268 |
2,112 |
$122K |
| 76770 |
|
740 |
733 |
$121K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
10,829 |
9,797 |
$120K |
| D1120 |
Prophylaxis - child |
3,517 |
3,365 |
$113K |
| 97530 |
Therapeutic activities, direct patient contact, each 15 minutes |
715 |
114 |
$113K |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
7,003 |
6,898 |
$111K |
| 95012 |
|
1,790 |
1,655 |
$108K |
| 74019 |
|
1,451 |
1,414 |
$97K |
| 76820 |
|
1,116 |
655 |
$96K |
| 76825 |
|
176 |
165 |
$91K |
| 86141 |
|
4,498 |
4,058 |
$86K |
| 87420 |
|
3,129 |
3,060 |
$84K |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
238 |
233 |
$74K |
| D1208 |
Topical application of fluoride, excluding varnish |
5,387 |
5,165 |
$71K |
| 81001 |
|
14,748 |
14,292 |
$71K |
| 86317 |
|
583 |
258 |
$67K |
| 87081 |
|
6,138 |
5,995 |
$66K |
| 0240U |
|
6,576 |
6,487 |
$61K |
| D0145 |
Oral evaluation for a patient under three years of age |
490 |
463 |
$60K |
| 74018 |
|
1,102 |
1,072 |
$59K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
4,646 |
4,528 |
$58K |
| 69210 |
|
178 |
157 |
$55K |
| 73100 |
|
839 |
631 |
$53K |
| 94060 |
|
119 |
104 |
$51K |
| 84443 |
Thyroid stimulating hormone (TSH) |
2,118 |
2,074 |
$51K |
| D1110 |
Prophylaxis - adult |
1,029 |
987 |
$50K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
3,283 |
3,222 |
$48K |
| 95782 |
|
28 |
28 |
$44K |
| 29075 |
|
262 |
249 |
$42K |
| 85027 |
|
3,450 |
2,836 |
$31K |
| 96413 |
Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance |
103 |
87 |
$31K |
| 93325 |
|
175 |
120 |
$30K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
684 |
646 |
$29K |
| 84439 |
|
2,237 |
2,186 |
$29K |
| 72170 |
|
675 |
609 |
$28K |
| 76705 |
Ultrasound, abdominal, real time with image documentation; limited |
143 |
136 |
$26K |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
535 |
531 |
$26K |
| J0561 |
Injection, penicillin g benzathine, 100,000 units |
67 |
63 |
$26K |
| 67311 |
|
14 |
14 |
$25K |
| 86003 |
|
311 |
176 |
$24K |
| 76827 |
|
175 |
164 |
$24K |
| 97802 |
|
602 |
586 |
$22K |
| J8540 |
Dexamethasone, oral, 0.25 mg |
6,460 |
5,721 |
$22K |
| 41899 |
Unlisted procedure, dentoalveolar structures |
13 |
13 |
$19K |
| 77073 |
|
267 |
263 |
$18K |
| D0220 |
Intraoral - periapical first radiographic image |
1,738 |
1,647 |
$18K |
| D0272 |
Bitewings - two radiographic images |
860 |
816 |
$17K |
| 85007 |
|
3,162 |
2,597 |
$16K |
| J0585 |
Injection, onabotulinumtoxina, 1 unit |
54 |
51 |
$16K |
| 0202U |
Oncology (prostate), multianalyte, gene expression profiling |
2,234 |
2,195 |
$16K |
| D1351 |
Sealant - per tooth |
651 |
172 |
$15K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
150 |
139 |
$15K |
| 94644 |
|
110 |
104 |
$15K |
| 72081 |
|
303 |
279 |
$15K |
| D8670 |
Periodic orthodontic treatment visit |
244 |
242 |
$15K |
| 82784 |
|
806 |
416 |
$15K |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
27 |
27 |
$14K |
| 80069 |
|
1,187 |
1,106 |
$14K |
| 71045 |
Radiologic examination, chest; single view |
342 |
336 |
$13K |
| 76805 |
Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation |
59 |
54 |
$12K |
| 85652 |
|
3,204 |
2,806 |
$12K |
| 83735 |
|
1,307 |
1,226 |
$11K |
| 0002A |
|
572 |
561 |
$11K |
| 0001A |
|
664 |
643 |
$11K |
| 92555 |
|
169 |
162 |
$10K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
5,425 |
5,339 |
$10K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
70 |
70 |
$10K |
| D7140 |
Extraction, erupted tooth or exposed root |
230 |
141 |
$10K |
| 73560 |
|
160 |
135 |
$10K |
| 64642 |
|
59 |
57 |
$9K |
| 82728 |
|
433 |
380 |
$9K |
| D9230 |
Inhalation of nitrous oxide / analgesia, anxiolysis |
381 |
360 |
$9K |
| 82787 |
|
564 |
247 |
$9K |
| 31720 |
|
96 |
93 |
$9K |
| 82785 |
|
376 |
240 |
$8K |
| J7030 |
Infusion, normal saline solution , 1000 cc |
1,394 |
1,225 |
$8K |
| D0274 |
Bitewings - four radiographic images |
293 |
280 |
$8K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
93 |
75 |
$8K |
| 78264 |
|
14 |
14 |
$8K |
| 86160 |
|
436 |
221 |
$8K |
| D0150 |
Comprehensive oral evaluation - new or established patient |
241 |
232 |
$7K |
| D0230 |
Intraoral - periapical each additional radiographic image |
800 |
309 |
$7K |
| 36415 |
Collection of venous blood by venipuncture |
32,619 |
28,848 |
$7K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
183 |
175 |
$7K |
| 0072A |
|
156 |
153 |
$7K |
| 86225 |
|
315 |
265 |
$6K |
| 77072 |
|
131 |
130 |
$6K |
| 92557 |
|
44 |
40 |
$6K |
| 83516 |
|
519 |
268 |
$6K |
| 29065 |
|
14 |
12 |
$6K |
| 78262 |
|
14 |
14 |
$5K |
| D0140 |
Limited oral evaluation - problem focused |
320 |
304 |
$5K |
| 92552 |
|
48 |
48 |
$5K |
| 93225 |
|
27 |
25 |
$5K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
213 |
191 |
$4K |
| D0330 |
Panoramic radiographic image |
125 |
121 |
$4K |
| 84999 |
|
44 |
43 |
$4K |
| 73140 |
|
46 |
38 |
$4K |
| 84305 |
|
130 |
128 |
$4K |
| 83993 |
|
115 |
113 |
$4K |
| 90472 |
Immunization administration, each additional vaccine (list separately) |
1,149 |
1,134 |
$4K |
| 81025 |
|
258 |
245 |
$3K |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
836 |
758 |
$3K |
| 83690 |
|
301 |
296 |
$3K |
| 80076 |
|
252 |
247 |
$3K |
| 82977 |
|
311 |
297 |
$3K |
| D2391 |
Resin-based composite - one surface, posterior, primary or permanent |
38 |
25 |
$3K |
| 80061 |
Lipid panel |
163 |
160 |
$3K |
| 86364 |
|
149 |
108 |
$3K |
| 80180 |
|
94 |
86 |
$3K |
| 99201 |
|
137 |
136 |
$3K |
| J7120 |
Ringers lactate infusion, up to 1000 cc |
966 |
798 |
$3K |
| 80320 |
|
145 |
138 |
$3K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
29 |
27 |
$3K |
| 0071A |
|
66 |
64 |
$3K |
| 82570 |
|
366 |
303 |
$3K |
| 73070 |
|
35 |
27 |
$2K |
| 86235 |
|
49 |
26 |
$2K |
| 70450 |
Computed tomography, head or brain; without contrast material |
12 |
12 |
$2K |
| J2930 |
Injection, methylprednisolone sodium succinate, up to 125 mg |
64 |
42 |
$2K |
| D0160 |
|
165 |
157 |
$2K |
| J7042 |
5% dextrose/normal saline (500 ml = 1 unit) |
289 |
210 |
$2K |
| 76817 |
Ultrasound, pregnant uterus, real time with image documentation, transvaginal |
12 |
12 |
$2K |
| 92556 |
|
27 |
27 |
$2K |
| 85045 |
|
279 |
247 |
$2K |
| 92582 |
|
27 |
27 |
$2K |
| 84156 |
|
305 |
254 |
$2K |
| 92583 |
|
43 |
42 |
$1K |
| 92504 |
|
50 |
49 |
$1K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
225 |
203 |
$1K |
| 82610 |
|
80 |
77 |
$1K |
| 36591 |
|
38 |
24 |
$1K |
| 87040 |
|
88 |
86 |
$1K |
| 73090 |
|
31 |
24 |
$1K |
| 86480 |
|
19 |
18 |
$1K |
| 81002 |
|
290 |
286 |
$1K |
| 73080 |
|
16 |
14 |
$1K |
| 99215 |
Prolong outpt/office vis |
13 |
12 |
$988.72 |
| 73562 |
|
14 |
13 |
$987.22 |
| 80048 |
Basic metabolic panel (calcium, ionized) |
57 |
55 |
$979.34 |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
745 |
677 |
$961.15 |
| 83550 |
|
70 |
68 |
$952.76 |
| J2919 |
Injection, methylprednisolone sodium succinate, 5 mg |
93 |
63 |
$938.73 |
| 83615 |
|
83 |
71 |
$907.07 |
| 86200 |
|
53 |
53 |
$807.60 |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
24 |
24 |
$737.63 |
| 83540 |
|
70 |
68 |
$722.38 |
| 90686 |
|
2,325 |
2,270 |
$643.03 |
| 0081A |
|
30 |
30 |
$599.23 |
| 81003 |
|
169 |
160 |
$548.02 |
| 88304 |
|
87 |
81 |
$533.56 |
| 83520 |
|
14 |
12 |
$418.18 |
| D0170 |
|
30 |
27 |
$358.93 |
| 86039 |
|
27 |
26 |
$354.67 |
| 84100 |
|
78 |
78 |
$338.00 |
| 87338 |
|
15 |
15 |
$295.94 |
| 86256 |
|
27 |
24 |
$276.67 |
| 86812 |
|
14 |
14 |
$260.54 |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
466 |
387 |
$217.44 |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
17 |
12 |
$206.35 |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
16 |
12 |
$206.34 |
| 82550 |
|
14 |
14 |
$201.07 |
| 83525 |
|
14 |
14 |
$182.62 |
| D1354 |
|
45 |
14 |
$175.50 |
| 90474 |
|
37 |
37 |
$49.76 |
| J0665 |
Injection, bupivicaine, not otherwise specified, 0.5 mg |
36 |
31 |
$48.55 |
| J0171 |
Injection, adrenalin, epinephrine, 0.1 mg |
18 |
17 |
$42.92 |
| J7050 |
Infusion, normal saline solution, 250 cc |
30 |
24 |
$40.86 |
| J0690 |
Injection, cefazolin sodium, 500 mg |
34 |
29 |
$38.91 |
| 36416 |
|
429 |
376 |
$31.75 |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
52 |
41 |
$24.76 |
| 90670 |
|
190 |
189 |
$20.06 |
| 90680 |
|
25 |
25 |
$0.13 |
| D9986 |
|
45 |
45 |
$0.00 |
| D0603 |
|
5,364 |
5,116 |
$0.00 |
| D0602 |
|
755 |
726 |
$0.00 |
| J1642 |
Injection, heparin sodium, (heparin lock flush), per 10 units |
47 |
25 |
$0.00 |
| 90698 |
|
96 |
96 |
$0.00 |
| L8699 |
Prosthetic implant, not otherwise specified |
42 |
42 |
$0.00 |
| 82962 |
|
14 |
12 |
$0.00 |